Direct oral anticoagulation and mortality in moderate to high-risk atrial fibrillation.
Ronen ArbelRuslan SergienkoAriel HammermanSari Dotan-GreenbergErez BatatOrly AvneryDan GreenbergMartin H EllisPublished in: Heart (British Cardiac Society) (2019)
In this cohort of newly diagnosed patients with NVAF, DOAC therapy was associated with a significantly lower risk of death compared with no oral anticoagulation. Our findings provide further evidence for the importance of providing DOAC anticoagulation in patients with NVAF.
Keyphrases
- atrial fibrillation
- direct oral anticoagulants
- venous thromboembolism
- newly diagnosed
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- heart failure
- percutaneous coronary intervention
- cardiovascular events
- type diabetes
- acute coronary syndrome
- coronary artery disease
- left ventricular
- mitral valve